Determination of berberine-upregulated endogenous short-chain fatty acids through derivatization by 2-bromoacetophenone
Shurong Ma(Dalian Medical University), Jian‐Dong Jiang(Ningbo University), Ran Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinbo Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Wang(Fujian Normal University), Lin Cong, Jie Fu(Zhejiang University), Zhengwei Zhang(Anhui Medical University), Pei Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Randy Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qian Tong(Jilin University), Zhenxiong Zhao(Shanghai Medical College of Fudan University), Li‐Bin Pan(Zhejiang Cancer Hospital)
Cited by 31
Related Papers
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
|Drug Design Development and Therapy|2021|377
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
|Signal Transduction and Targeted Therapy|2021|315
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
|Acta Pharmaceutica Sinica B|2019|217
Mechanisms and regulation of defensins in host defense
|Signal Transduction and Targeted Therapy|2023|198